Low skull bone density is associated with poor motor prognosis in women with Parkinson’s disease

Parkinson’s disease (PD) and osteoporosis are degenerative diseases that have shared pathomechanisms. To investigate the associations of skull bone density with nigrostriatal dopaminergic degeneration and longitudinal motor prognosis in female patients with PD. We analyzed the data of 260 drug-naïve...

Full description

Bibliographic Details
Main Authors: Seong Ho Jeong, Namki Hong, Hye Sun Lee, Sookyeong Han, Young-gun Lee, Yoonju Lee, Yumie Rhee, Young H. Sohn, Phil Hyu Lee
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2022.1053786/full
_version_ 1811180225588887552
author Seong Ho Jeong
Seong Ho Jeong
Namki Hong
Hye Sun Lee
Sookyeong Han
Young-gun Lee
Yoonju Lee
Yoonju Lee
Yumie Rhee
Young H. Sohn
Phil Hyu Lee
Phil Hyu Lee
author_facet Seong Ho Jeong
Seong Ho Jeong
Namki Hong
Hye Sun Lee
Sookyeong Han
Young-gun Lee
Yoonju Lee
Yoonju Lee
Yumie Rhee
Young H. Sohn
Phil Hyu Lee
Phil Hyu Lee
author_sort Seong Ho Jeong
collection DOAJ
description Parkinson’s disease (PD) and osteoporosis are degenerative diseases that have shared pathomechanisms. To investigate the associations of skull bone density with nigrostriatal dopaminergic degeneration and longitudinal motor prognosis in female patients with PD. We analyzed the data of 260 drug-naïve female PD patients aged ≥50 years old who were followed-up for ≥3 years after their first visit to the clinic with baseline dopamine transporter (DAT) imaging. We measured skull bone density as a surrogate marker for systemic bone loss by calculating the Hounsfield unit (HU) in computed tomography scans. A Cox proportional hazard model was built to compare the rates of levodopa-induced dyskinesia (LID) or wearing-off according to skull HU. Longitudinal changes in levodopa-equivalent dose (LED) during a 3-year follow-up were assessed using a linear mixed model. A lower skull HU was associated with lower baseline DAT availability in striatal subregions; however, this relationship was not significant after adjusting for age, disease duration, body mass index, and white matter hyperintensities. After adjusting for confounding factors, a lower skull HU was significantly associated with an increased risk of LID development (hazard ratio = 1.660 per 1 standard deviation decrease, p = 0.007) and wearing-off (hazard ratio = 1.613, p = 0.016) in younger (<67 years) but not in older patients. Furthermore, a lower skull HU was associated with a steeper increase in LED during follow-up in younger patients only (β = –21.99, p < 0.001). This study suggests that baseline skull bone density would be closely linked to motor prognosis in drug naïve women with PD.
first_indexed 2024-04-11T06:46:41Z
format Article
id doaj.art-33a5c562f08d41a19236a03cd5e4e14f
institution Directory Open Access Journal
issn 1663-4365
language English
last_indexed 2024-04-11T06:46:41Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Aging Neuroscience
spelling doaj.art-33a5c562f08d41a19236a03cd5e4e14f2022-12-22T04:39:19ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652022-11-011410.3389/fnagi.2022.10537861053786Low skull bone density is associated with poor motor prognosis in women with Parkinson’s diseaseSeong Ho Jeong0Seong Ho Jeong1Namki Hong2Hye Sun Lee3Sookyeong Han4Young-gun Lee5Yoonju Lee6Yoonju Lee7Yumie Rhee8Young H. Sohn9Phil Hyu Lee10Phil Hyu Lee11Department of Neurology, Yonsei University College of Medicine, Seoul, South KoreaDepartment of Neurology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, South KoreaDepartment of Internal Medicine, Severance Hospital, Endocrine Research Institute, Yonsei University College of Medicine, Seoul, South KoreaBiostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, South KoreaEndocrine Research Institute, Severance Hospital, Seoul, South KoreaDepartment of Neurology, Yonsei University College of Medicine, Seoul, South KoreaDepartment of Neurology, Yonsei University College of Medicine, Seoul, South KoreaDepartment of Health Promotion, Severance Health Check-Up, Severance Hospital, Yonsei University Health System, Seoul, South KoreaDepartment of Internal Medicine, Severance Hospital, Endocrine Research Institute, Yonsei University College of Medicine, Seoul, South KoreaDepartment of Neurology, Yonsei University College of Medicine, Seoul, South KoreaDepartment of Neurology, Yonsei University College of Medicine, Seoul, South KoreaSeverance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South KoreaParkinson’s disease (PD) and osteoporosis are degenerative diseases that have shared pathomechanisms. To investigate the associations of skull bone density with nigrostriatal dopaminergic degeneration and longitudinal motor prognosis in female patients with PD. We analyzed the data of 260 drug-naïve female PD patients aged ≥50 years old who were followed-up for ≥3 years after their first visit to the clinic with baseline dopamine transporter (DAT) imaging. We measured skull bone density as a surrogate marker for systemic bone loss by calculating the Hounsfield unit (HU) in computed tomography scans. A Cox proportional hazard model was built to compare the rates of levodopa-induced dyskinesia (LID) or wearing-off according to skull HU. Longitudinal changes in levodopa-equivalent dose (LED) during a 3-year follow-up were assessed using a linear mixed model. A lower skull HU was associated with lower baseline DAT availability in striatal subregions; however, this relationship was not significant after adjusting for age, disease duration, body mass index, and white matter hyperintensities. After adjusting for confounding factors, a lower skull HU was significantly associated with an increased risk of LID development (hazard ratio = 1.660 per 1 standard deviation decrease, p = 0.007) and wearing-off (hazard ratio = 1.613, p = 0.016) in younger (<67 years) but not in older patients. Furthermore, a lower skull HU was associated with a steeper increase in LED during follow-up in younger patients only (β = –21.99, p < 0.001). This study suggests that baseline skull bone density would be closely linked to motor prognosis in drug naïve women with PD.https://www.frontiersin.org/articles/10.3389/fnagi.2022.1053786/fullParkinson’s diseaseosteopenia/osteoporosisdopamine transporter (DAT) imagingprognosisskull bone density
spellingShingle Seong Ho Jeong
Seong Ho Jeong
Namki Hong
Hye Sun Lee
Sookyeong Han
Young-gun Lee
Yoonju Lee
Yoonju Lee
Yumie Rhee
Young H. Sohn
Phil Hyu Lee
Phil Hyu Lee
Low skull bone density is associated with poor motor prognosis in women with Parkinson’s disease
Frontiers in Aging Neuroscience
Parkinson’s disease
osteopenia/osteoporosis
dopamine transporter (DAT) imaging
prognosis
skull bone density
title Low skull bone density is associated with poor motor prognosis in women with Parkinson’s disease
title_full Low skull bone density is associated with poor motor prognosis in women with Parkinson’s disease
title_fullStr Low skull bone density is associated with poor motor prognosis in women with Parkinson’s disease
title_full_unstemmed Low skull bone density is associated with poor motor prognosis in women with Parkinson’s disease
title_short Low skull bone density is associated with poor motor prognosis in women with Parkinson’s disease
title_sort low skull bone density is associated with poor motor prognosis in women with parkinson s disease
topic Parkinson’s disease
osteopenia/osteoporosis
dopamine transporter (DAT) imaging
prognosis
skull bone density
url https://www.frontiersin.org/articles/10.3389/fnagi.2022.1053786/full
work_keys_str_mv AT seonghojeong lowskullbonedensityisassociatedwithpoormotorprognosisinwomenwithparkinsonsdisease
AT seonghojeong lowskullbonedensityisassociatedwithpoormotorprognosisinwomenwithparkinsonsdisease
AT namkihong lowskullbonedensityisassociatedwithpoormotorprognosisinwomenwithparkinsonsdisease
AT hyesunlee lowskullbonedensityisassociatedwithpoormotorprognosisinwomenwithparkinsonsdisease
AT sookyeonghan lowskullbonedensityisassociatedwithpoormotorprognosisinwomenwithparkinsonsdisease
AT younggunlee lowskullbonedensityisassociatedwithpoormotorprognosisinwomenwithparkinsonsdisease
AT yoonjulee lowskullbonedensityisassociatedwithpoormotorprognosisinwomenwithparkinsonsdisease
AT yoonjulee lowskullbonedensityisassociatedwithpoormotorprognosisinwomenwithparkinsonsdisease
AT yumierhee lowskullbonedensityisassociatedwithpoormotorprognosisinwomenwithparkinsonsdisease
AT younghsohn lowskullbonedensityisassociatedwithpoormotorprognosisinwomenwithparkinsonsdisease
AT philhyulee lowskullbonedensityisassociatedwithpoormotorprognosisinwomenwithparkinsonsdisease
AT philhyulee lowskullbonedensityisassociatedwithpoormotorprognosisinwomenwithparkinsonsdisease